Key facts
- This page summarizes Craig E. Coleman's Form 4 filing for UNIVERSAL BIOSENSORS INC.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Sep 2023, 06:34.
Craig E. Coleman - 11 Sep 2023 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 11 Sep 2023
- Net transaction value
- +$22,000
- SEC form
- 4
- Accepted by SEC
- 13 Sep 2023, 06:34:01 UTC
- Prior SEC filing
- 16 Nov 2022
- Next SEC filing
- 26 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David St. Quintin, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Craig E. Coleman filed Form 4 for UNIVERSAL BIOSENSORS INC on 13 Sep 2023.
Change
- Previous filing in this sequence was filed on 16 Nov 2022.
- Current net transaction value: +$22,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
UBI
transaction
Common Stock
Purchase
- Transaction value
- $22,000
- Shares
- +100,000
- Change %
- +15%
- Price
- $0.2200*
- Shares after
- 753,620
- Date
- 11 Sep 2023
- Ownership
- By the Coleman Super Fund
- Footnotes
- F1, F2, F5
UBI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 55,798,601
- Date
- 11 Sep 2023
- Ownership
- By Partnership
- Footnotes
- F1, F3, F4
UBI
holding
Stock Option (Right to Buy - Exercise Price $0.20)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,000,000
- Date
- 11 Sep 2023
- Ownership
- By Partnership
- Footnotes
- F2, F3, F6
UBI
holding
Stock Option (Right to Buy - Exercise Price $0.92)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,920,000
- Date
- 11 Sep 2023
- Ownership
- By Partnership
- Footnotes
- F2, F3, F7
UBI
holding
Stock Option (Right to Buy - Exercise Price $1.00)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,920,000
- Date
- 11 Sep 2023
- Ownership
- By Partnership
- Footnotes
- F2, F3, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Traded as Chess Depository Interests ("CDIs") on the Australian Stock Exchange. CDIs represent beneficial interests in the common stock held by CHESS Depository Nominees Pty Ltd.
Footnote F2
The price reported is stated in Australian dollars.
Footnote F3
The Reporting Person is a director of Viburnum, which is the manager of each of VF Strategic Equities Fund ("Strategic Fund") and separately managed accounts on behalf of a Viburnum client ("Strategic Mandates") the direct beneficial owners of the common stock and stock options. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the common stock and stock options held by Strategic Fund, and Strategic Mandates, except to the extent of his pecuniary interest therein.
Footnote F4
Viburnum, as the manager of Strategic Fund and Strategic Mandates, may be deemed to beneficially own 55,798,601 shares of common stock, which consists of 22,169,559 and 33,629,042 shares of common stock held by Strategic Fund and Strategic Mandates, respectively. Viburnum, as the manager of each of Strategic Fund and Strategic Mandates, shares voting and dispositive power over, and may be deemed to beneficially own, the common stock held by the foregoing entities. The Reporting Person shares voting and dispositive power over, and may be deemed to beneficially own, the common stock held by the foregoing entities due to the Reporting Person serving as a director of Viburnum.
Footnote F5
Craig E. and Phylis Coleman are the trustees of the Coleman Super Fund, of which Mr. Coleman is a potential beneficiary.
Footnote F6
Viburnum, as the manager of Strategic Fund may be deemed to beneficially own 1,000,000 stock options which an exercise price of A$0.20 and expiry date of 03/24/2024.
Footnote F7
Viburnum, as the manager of Strategic Fund and Strategic Mandates, may be deemed to beneficially own 1,920,000 stock options which an exercise price of A$0.92 and expiry date of 05/26/2025.
Footnote F8
Viburnum, as the manager of Strategic Fund and Strategic Mandates, may be deemed to beneficially own 1,920,000 stock options which an exercise price of A$1.00 and expiry date of 05/26/2025.